Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Trimegah Karya Pratama Tbk. (UVCR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Trimegah Karya Pratama Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 292,02 M, volume 24 jam 23,22 jt). Perbedaan utamanya: Trimegah Karya Pratama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Trimegah Karya Pratama Tbk. lebih aktif diperdagangkan (23,22 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 164,65 M | 292,02 M |
Volume | 187,4 rb | 23,22 jt |
Lot | 1,87 rb | 232,24 rb |
Perputaran | 44,35 jt | 3,36 M |
Harga Rata-rata | 236,67 | 144,89 |
Nilai Transaksi | 44,35 jt | 3,36 M |
Harga Ekuilibrium Indikatif | 242 | 146 |
Volume Ekuilibrium Indikatif | 500 | 410 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Tentang Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →
